Total Payments
$476.70
2024 Payments
$105.55
Companies
11
Transactions
23
Medicare Patients
3,090
Medicare Billing
$201,843
Payment Breakdown by Category
Food & Beverage$417.20 (87.5%)
Education$59.50 (12.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $417.20 | 19 | 87.5% |
| Education | $59.50 | 4 | 12.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $133.35 | 8 | $0 (2024) |
| Seagen Inc. | $64.69 | 2 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $60.08 | 3 | $0 (2024) |
| Daiichi Sankyo Inc. | $57.03 | 2 | $0 (2024) |
| PFIZER INC. | $50.00 | 1 | $0 (2017) |
| Novartis Pharmaceuticals Corporation | $37.03 | 2 | $0 (2019) |
| BeiGene USA, Inc. | $18.31 | 1 | $0 (2024) |
| TerSera Therapeutics LLC | $17.82 | 1 | $0 (2018) |
| Janssen Biotech, Inc. | $15.07 | 1 | $0 (2019) |
| Gilead Sciences, Inc. | $11.92 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $105.55 | 5 | Merck Sharp & Dohme LLC ($36.18) |
| 2023 | $130.74 | 5 | Seagen Inc. ($64.69) |
| 2021 | $23.32 | 2 | Gilead Sciences, Inc. ($11.92) |
| 2020 | $14.82 | 1 | Merck Sharp & Dohme Corporation ($14.82) |
| 2019 | $49.02 | 3 | Novartis Pharmaceuticals Corporation ($18.19) |
| 2018 | $66.60 | 4 | Merck Sharp & Dohme Corporation ($29.94) |
| 2017 | $86.65 | 3 | PFIZER INC. ($50.00) |
All Payment Transactions
23 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/15/2024 | Merck Sharp & Dohme LLC | WELIREG (Drug) | Education | In-kind items and services | $18.09 | General |
| Category: ONCOLOGY | ||||||
| 10/26/2024 | Merck Sharp & Dohme LLC | WELIREG (Drug) | Education | In-kind items and services | $18.09 | General |
| Category: ONCOLOGY | ||||||
| 09/18/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $29.12 | General |
| Category: ONCOLOGY | ||||||
| 06/19/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $18.31 | General |
| Category: Oncology | ||||||
| 04/24/2024 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Food and Beverage | In-kind items and services | $21.94 | General |
| Category: Oncology | ||||||
| 12/19/2023 | Seagen Inc. | TUKYSA (Drug) | Food and Beverage | In-kind items and services | $32.21 | General |
| Category: Oncology | ||||||
| 12/13/2023 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Food and Beverage | In-kind items and services | $18.97 | General |
| Category: Oncology | ||||||
| 09/26/2023 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $27.91 | General |
| Category: ONCOLOGY | ||||||
| 04/05/2023 | Seagen Inc. | TUKYSA (Drug) | Food and Beverage | In-kind items and services | $32.48 | General |
| Category: Oncology | ||||||
| 03/16/2023 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Food and Beverage | In-kind items and services | $19.17 | General |
| Category: Oncology | ||||||
| 12/09/2021 | ADC Therapeutics America, Inc. | — | Education | In-kind items and services | $11.40 | General |
| 06/01/2021 | Gilead Sciences, Inc. | — | Education | In-kind items and services | $11.92 | General |
| 01/27/2020 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: ONCOLOGY | ||||||
| 10/24/2019 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological), LENVIMA | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: ONCOLOGY | ||||||
| 06/13/2019 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: ONCOLOGY | ||||||
| 05/11/2019 | Janssen Biotech, Inc. | Balversa (Drug) | Food and Beverage | In-kind items and services | $15.07 | General |
| Category: Oncology | ||||||
| 10/25/2018 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $15.80 | General |
| 07/07/2018 | TerSera Therapeutics LLC | ZOLADEX (Drug) | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: ONCOLOGY | ||||||
| 01/23/2018 | Novartis Pharmaceuticals Corporation | AFINITOR (Drug), TYKERB | Food and Beverage | In-kind items and services | $18.84 | General |
| Category: ONCOLOGY | ||||||
| 01/18/2018 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $14.14 | General |
| Category: ONCOLOGY | ||||||
| 07/06/2017 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: ONCOLOGY | ||||||
| 05/04/2017 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: ONCOLOGY | ||||||
| 02/20/2017 | PFIZER INC. | IBRANCE (Drug) | Food and Beverage | In-kind items and services | $50.00 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 542 | 1,199 | $95,799 | $38,632 |
| 2022 | 8 | 609 | 1,342 | $109,540 | $42,115 |
| 2021 | 10 | 937 | 2,065 | $163,894 | $66,192 |
| 2020 | 10 | 1,002 | 2,318 | $159,879 | $54,905 |
Total Patients
3,090
Total Services
6,924
Medicare Billing
$201,843
Procedure Codes
36
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 190 | 328 | $49,856 | $20,204 | 40.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 52 | 99 | $22,077 | $9,425 | 42.7% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 74 | 225 | $8,550 | $2,329 | 27.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 92 | 243 | $2,857 | $2,041 | 71.4% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 76 | 245 | $6,860 | $1,864 | 27.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 19 | 19 | $2,793 | $1,367 | 48.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 16 | 17 | $1,564 | $714.88 | 45.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 23 | 23 | $1,242 | $687.06 | 55.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 197 | 361 | $54,137 | $22,513 | 41.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 87 | 140 | $30,836 | $11,664 | 37.8% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 80 | 230 | $8,740 | $2,404 | 27.5% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 92 | 285 | $7,980 | $2,191 | 27.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 16 | 16 | $2,352 | $1,097 | 46.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 18 | 23 | $2,102 | $925.12 | 44.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 101 | 269 | $2,421 | $798.87 | 33.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 18 | 18 | $972.00 | $521.64 | 53.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 228 | 457 | $68,093 | $29,550 | 43.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 147 | 250 | $54,750 | $23,395 | 42.7% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2021 | 124 | 349 | $13,262 | $3,685 | 27.8% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2021 | 134 | 421 | $11,788 | $3,271 | 27.8% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 27 | 27 | $2,376 | $1,762 | 74.2% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 26 | 31 | $2,821 | $1,252 | 44.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 151 | 375 | $3,375 | $1,125 | 33.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 11 | 11 | $3,685 | $1,088 | 29.5% |
| 83615 | Lactate dehydrogenase (enzyme) level | Office | 2021 | 71 | 126 | $2,772 | $761.04 | 27.5% |
About Dr. Susan Luedke, M.D
Dr. Susan Luedke, M.D is a Medical Oncology healthcare provider based in Saint Louis, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1679519508.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Susan Luedke, M.D has received a total of $476.70 in payments from pharmaceutical and medical device companies, with $105.55 received in 2024. These payments were reported across 23 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($417.20).
As a Medicare-enrolled provider, Luedke has provided services to 3,090 Medicare beneficiaries, totaling 6,924 services with total Medicare billing of $201,843. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Ad
Practice Information
- Specialty Medical Oncology
- Other Specialties Hematology & Oncology
- Location Saint Louis, MO
- Active Since 06/20/2006
- Last Updated 12/15/2010
- Taxonomy Code 207RX0202X
- Entity Type Individual
- NPI Number 1679519508
Products in Payments
- KEYTRUDA (Biological) $81.37
- TUKYSA (Drug) $64.69
- ENHERTU (Biological) $60.08
- Enhertu (Drug) $57.03
- IBRANCE (Drug) $50.00
- WELIREG (Drug) $36.18
- AFINITOR (Drug) $18.84
- BRUKINSA (Drug) $18.31
- KISQALI (Drug) $18.19
- ZOLADEX (Drug) $17.82
- Balversa (Drug) $15.07
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Medical Oncology Doctors in Saint Louis
Dr. Brad Kahl, Md, MD
Medical Oncology — Payments: $379,829
Medical Oncology $379,829
Dr. Russell Pachynski, Md, MD
Medical Oncology — Payments: $362,594
Medical Oncology $362,594
Dr. Mark Schroeder, Md, MD
Medical Oncology — Payments: $337,205
Medical Oncology $337,205
Dr. Ravi Vij, Md, MD
Medical Oncology — Payments: $262,216
Medical Oncology $262,216
Dr. Douglas Adkins, Md, MD
Medical Oncology — Payments: $166,184
Medical Oncology $166,184
Dr. Camille Abboud, Md, MD
Medical Oncology — Payments: $155,687
Medical Oncology $155,687